These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32878883)

  • 21. Pharmacological Protein Kinase C Modulators Reveal a Pro-hypertrophic Role for Novel Protein Kinase C Isoforms in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Pohjolainen L; Easton J; Solanki R; Ruskoaho H; Talman V
    Front Pharmacol; 2020; 11():553852. PubMed ID: 33584253
    [No Abstract]   [Full Text] [Related]  

  • 22. Stem cell-derived extracellular vesicles reduce the expression of molecules involved in cardiac hypertrophy-In a model of human-induced pluripotent stem cell-derived cardiomyocytes.
    Constantin A; Comarița IK; Alexandru N; Filippi A; Bojin F; Gherghiceanu M; Vîlcu A; Nemecz M; Niculescu LS; Păunescu V; Georgescu A
    Front Pharmacol; 2022; 13():1003684. PubMed ID: 36299891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes.
    Kopljar I; De Bondt A; Vinken P; Teisman A; Damiano B; Goeminne N; Van den Wyngaert I; Gallacher DJ; Lu HR
    Br J Pharmacol; 2017 Nov; 174(21):3766-3779. PubMed ID: 28094846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential ERK1/2 Signaling and Hypertrophic Response to Endothelin-1 in Cardiomyocytes from SHR and Wistar-Kyoto Rats: A Potential Target for Combination Therapy of Hypertension.
    Zhu LA; Fang NY; Gao PJ; Jin X; Wang HY; Liu Z
    Curr Vasc Pharmacol; 2015; 13(4):467-74. PubMed ID: 25360842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binary Colloidal Crystals Drive Spheroid Formation and Accelerate Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cui C; Wang J; Qian D; Huang J; Lin J; Kingshott P; Wang PY; Chen M
    ACS Appl Mater Interfaces; 2019 Jan; 11(4):3679-3689. PubMed ID: 30614683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis.
    Parveen S; Singh SP; Panicker MM; Gupta PK
    In Vitro Cell Dev Biol Anim; 2019 Apr; 55(4):272-284. PubMed ID: 30798515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrophysiologic Characterization of Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes.
    Argenziano M; Lambers E; Hong L; Sridhar A; Zhang M; Chalazan B; Menon A; Savio-Galimberti E; Wu JC; Rehman J; Darbar D
    Stem Cell Reports; 2018 Jun; 10(6):1867-1878. PubMed ID: 29731429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation.
    Jung G; Fajardo G; Ribeiro AJ; Kooiker KB; Coronado M; Zhao M; Hu DQ; Reddy S; Kodo K; Sriram K; Insel PA; Wu JC; Pruitt BL; Bernstein D
    FASEB J; 2016 Apr; 30(4):1464-79. PubMed ID: 26675706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
    Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myogenin suppresses apoptosis induced by angiotensin II in human induced pluripotent stem cell-derived cardiomyocytes.
    Gao Q; Wang P; Qiu H; Qiu B; Yi W; Tu W; Lin B; Sun D; Zeng R; Huang M; Chen J; Cen J; Zhuang J
    Biochem Biophys Res Commun; 2021 May; 552():84-90. PubMed ID: 33743352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.
    Zhao M; Nakada Y; Wei Y; Bian W; Chu Y; Borovjagin AV; Xie M; Zhu W; Nguyen T; Zhou Y; Serpooshan V; Walcott GP; Zhang J
    Circulation; 2021 Jul; 144(3):210-228. PubMed ID: 33951921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RNA-Sequencing Analysis of Differentially Expressed Genes in Human iPSC-Derived Cardiomyocytes.
    Okubo C; Narita M; Yamamoto T; Yoshida Y
    Methods Mol Biol; 2021; 2320():193-217. PubMed ID: 34302660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Afterload promotes maturation of human induced pluripotent stem cell derived cardiomyocytes in engineered heart tissues.
    Leonard A; Bertero A; Powers JD; Beussman KM; Bhandari S; Regnier M; Murry CE; Sniadecki NJ
    J Mol Cell Cardiol; 2018 May; 118():147-158. PubMed ID: 29604261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with MYL2-R58Q-Mediated Apical Hypertrophic Cardiomyopathy Show Hypertrophy, Myofibrillar Disarray, and Calcium Perturbations.
    Zhou W; Bos JM; Ye D; Tester DJ; Hrstka S; Maleszewski JJ; Ommen SR; Nishimura RA; Schaff HV; Kim CS; Ackerman MJ
    J Cardiovasc Transl Res; 2019 Oct; 12(5):394-403. PubMed ID: 30796699
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring hypertrophy in neonatal rat primary cardiomyocytes and human iPSC-derived cardiomyocytes.
    Bourque K; Hawey C; Jones-Tabah J; Pétrin D; Martin RD; Ling Sun Y; Hébert TE
    Methods; 2022 Jul; 203():447-464. PubMed ID: 34933120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells.
    Han L; Li Y; Tchao J; Kaplan AD; Lin B; Li Y; Mich-Basso J; Lis A; Hassan N; London B; Bett GC; Tobita K; Rasmusson RL; Yang L
    Cardiovasc Res; 2014 Nov; 104(2):258-69. PubMed ID: 25209314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contractile Work Contributes to Maturation of Energy Metabolism in hiPSC-Derived Cardiomyocytes.
    Ulmer BM; Stoehr A; Schulze ML; Patel S; Gucek M; Mannhardt I; Funcke S; Murphy E; Eschenhagen T; Hansen A
    Stem Cell Reports; 2018 Mar; 10(3):834-847. PubMed ID: 29503093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling Human Cardiac Hypertrophy in Stem Cell-Derived Cardiomyocytes.
    Ovchinnikova E; Hoes M; Ustyantsev K; Bomer N; de Jong TV; van der Mei H; Berezikov E; van der Meer P
    Stem Cell Reports; 2018 Mar; 10(3):794-807. PubMed ID: 29456183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system.
    Kolanowski TJ; Busek M; Schubert M; Dmitrieva A; Binnewerg B; Pöche J; Fisher K; Schmieder F; Grünzner S; Hansen S; Richter A; El-Armouche A; Sonntag F; Guan K
    Acta Biomater; 2020 Jan; 102():273-286. PubMed ID: 31778832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes.
    Bizy A; Guerrero-Serna G; Hu B; Ponce-Balbuena D; Willis BC; Zarzoso M; Ramirez RJ; Sener MF; Mundada LV; Klos M; Devaney EJ; Vikstrom KL; Herron TJ; Jalife J
    Stem Cell Res; 2013 Nov; 11(3):1335-47. PubMed ID: 24095945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.